Aroesty Jason D 4
4 · HESKA CORP · Filed Jul 27, 2018
Insider Transaction Report
Form 4
HESKA CORPHSKA
Aroesty Jason D
EVP, International Diagnostics
Transactions
- Award
Incentive Stock Option (right to buy)
2018-07-25+2,811→ 2,811 totalExercise: $106.67Exp: 2028-07-24→ Common Stock (2,811 underlying) - Award
Performance Shares
2018-07-25+4,688→ 4,688 totalExp: 2025-03-31→ Common Stock (4,688 underlying) - Award
Non-Qualified Stock Option (right to buy)
2018-07-25+17,189→ 17,189 totalExercise: $106.67Exp: 2028-07-24→ Common Stock (17,189 underlying)
Footnotes (2)
- [F1]The aggregate of these two option awards vests in three approximately equal annual installments beginning on July 25, 2019 and ending on July 25, 2021.
- [F2]The vesting of each of three approximately equal performance share tranches is contingent on the achievement of certain market-vesting thresholds based on the price per share of Heska's common stock average over a 20-day trailing trading period. The first tranche is to vest at the achievement of $133.34 per share and the second anniversary of grant date. The second tranche is to vest at the achievement of $154.67 per share and the third anniversary of grant date. The third tranche is to vest at the achievement of $186.67 per share and the fourth anniversary of grant date. Any performance shares that do not vest by March 31, 2025 are to be forfeited.